Shaktikanta Das,Governor,RBI Robust growth provides space for...
Category:
Eco/Invest/Demography
Latest
Taiwan’s strict building codes, high awareness and people’s preparedness need to be replicated by India & others: Indian research scholar
At least 10 people died and more than 1,000 were injured on...
No increase in prices of essential medicines this fiscal year Mandaviya
"This year the inflation has not increased. It is just 0.005....
Oxford scientists develop five-minute COVID-19 antigen test
“Our method quickly detects intact virus particles,” said Professor Achilles Kapanidis, at Oxford’s Department of Physics, adding that this meant the test would be “simple, extremely rapid, and cost-effective”.
Rapid antigen tests are seen as key in rolling out mass-testing and re-opening economies while the coronavirus is still circulating, and those that are already in use are faster and cheaper but less accurate than existing molecular PCR tests.
IMF data shows pandemic will push China GDP growth well beyond US
Extreme poverty is set to rise for the first time in more than two decades, and persistent output losses imply a major setback to living standards versus the pre-pandemic days, the IMF said.“The poor are getting poorer with close to 90 million people expected to fall into extreme deprivation this year,” said Gopinath.
Health insurance premiums have risen by only 5%:IRDAI
“I would suggest that voluntary disclosures be made by all the hospitals and health providers so that public will chose looking at disclosures given by each hospitals where they would like to go and performance indicators might be also disclosed,” added SC Khuntia, chairman, IRDAI,.
India witnessing V-shaped recovery, govt steps to spur economic growth: FM
“She mentioned that the V-shaped pattern of recovery is being seen in several high-frequency indicators, including manufacturing PMI that reached the highest level in last eight years in the month of September 2020, presenting a strong recovery prospect for the manufacturing sector,” it said.
Risk Management: COVID-19 spurs collaboration and innovation
Risk management and transfer has always been about collaboration between client, broker and insurance carrier to find the most suitable solutions for risk problems. Without a doubt, the COVID-19 pandemic has forced us all to find different ways to do that – with the opportunity for face-to-face brainstorming put on hold, we need to find other ways to continue to innovate.
WHO study says remdesivir did not cut hospital stay or mortality in COVID-19 patients
“The emerging (WHO) data appears inconsistent, with more robust evidence from multiple randomized, controlled studies published in peer-reviewed journals validating the clinical benefit of remdesivir,” Gilead told Reuters.
“We are concerned the data from this open-label global trial has not undergone the rigorous review required to allow for constructive scientific discussion, particularly given the limitations of the trial design.”
COVID-19: 67,735 new cases take India’s virus tally to 73,07,097
There are 812390 active cases of coronavirus infection in the country which comprises 11.11 per cent of the total caseload, the data stated.
According to the ICMR, a cumulative total of 9,12,26,305 samples have been tested up to October 14 with 11,36,183 samples being tested on Wednesday
COVID-19 caseload in India rises to 72,39,389
There are 8,26,876 active cases of coronavirus infection in the country which comprises 11.42 per cent of the total caseload, while the recoveries have surged to 63,01,927, the data stated.
The COVID-19 case fatality rate was recorded at 1.53 per cent.
India to fall below Bangladesh in terms of per capita GDP in 2020
Going by the latest IMF estimate, India would be the third poorest nation in South Asia, with only Pakistan and Nepal reporting lower per capita GDP, whereas Bhutan, Bangladesh, Maldives, and Sri Lanka would outpace India.
However, India, Asia’s third-largest economy, is likely to bounce back with an impressive 8.8 per cent growth rate in 2021, thus regaining the position of the fastest growing emerging economy, surpassing China’s projected growth rate of 8.2 per cent, the IMF said.
Eli Lilly pauses trial of antibody drug Trump touted as COVID-19 ‘cure’ over safety concern
“Out of an abundance of caution, the ACTIV-3 independent data safety monitoring board (DSMB) has recommended a pause in enrollment.Lilly is supportive of the decision by the independent DSMB to cautiously ensure the safety of the patients participating in this study,”,” Lilly spokeswoman Molly McCully said in an emailed statement. “